AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI 
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports 
Google to Move All Pixel Production Out of China by 2027 
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3 
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside 
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
REPAY Stock Rises After Visa Platform Connect Collaboration 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Shein Targets $26B-$27B Valuation for Hong Kong IPO 
Add as a preferred source on Google
Olympus Korea will discontinue its camera business on June 30 due to low profitability and will shift its focus on medical equipment and science solutions.
The Korean unit of the Japan-headquartered firm that makes optics and photography products will also close its store and online shopping mall next month.
Olympus Korea will keep operating the service facility for repairing and exchanging products until March 31, 2026.
The company tried to improve its profitability with mirrorless cameras and interchangeable lenses, but as South Korea's camera market shrank considerably, it had to withdraw from the business.
Among Olympus Korea's other offerings are endoscopy and surgical equipment and microscopes.
The company has a medical training and education center in Incheon, which it opened in 2017.
Olympus Korea denied that their decision is in support of an ongoing anti-Japan sentiment and boycott all Japanese products in South Korea.
